588 related articles for article (PubMed ID: 15658878)
1. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD
J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878
[TBL] [Abstract][Full Text] [Related]
2. Quinols as novel therapeutic agents. 7.1 Synthesis of antitumor 4-[1-(arylsulfonyl-1H-indol-2-yl)]-4-hydroxycyclohexa-2,5-dien-1-ones by Sonogashira reactions.
McCarroll AJ; Bradshaw TD; Westwell AD; Matthews CS; Stevens MF
J Med Chem; 2007 Apr; 50(7):1707-10. PubMed ID: 17343370
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of antitumour (1H-1,2,3-triazol-4-yl)-4-hydroxycyclohexa-2,5-dien-1-ones by copper-catalysed Huisgen cycloadditions.
McCarroll AJ; Matthews CS; Wells G; Bradshaw TD; Stevens MF
Org Biomol Chem; 2010 May; 8(9):2078-84. PubMed ID: 20401384
[TBL] [Abstract][Full Text] [Related]
4. 4-Substituted 4-hydroxycyclohexa-2,5-dien-1-ones with selective activities against colon and renal cancer cell lines.
Wells G; Berry JM; Bradshaw TD; Burger AM; Seaton A; Wang B; Westwell AD; Stevens MF
J Med Chem; 2003 Feb; 46(4):532-41. PubMed ID: 12570375
[TBL] [Abstract][Full Text] [Related]
5. Antitumour properties of fluorinated benzothiazole-substituted hydroxycyclohexa-2,5-dienones ('quinols').
Lion CJ; Matthews CS; Wells G; Bradshaw TD; Stevens MF; Westwell AD
Bioorg Med Chem Lett; 2006 Oct; 16(19):5005-8. PubMed ID: 16908135
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor effect in vitro and in vivo of substituted 1,3-dihydroindole-2-ones.
Christensen MK; Erichsen KD; Trojel-Hansen C; Tjørnelund J; Nielsen SJ; Frydenvang K; Johansen TN; Nielsen B; Sehested M; Jensen PB; Ikaunieks M; Zaichenko A; Loza E; Kalvinsh I; Björkling F
J Med Chem; 2010 Oct; 53(19):7140-5. PubMed ID: 20845961
[TBL] [Abstract][Full Text] [Related]
7. Elucidation of thioredoxin as a molecular target for antitumor quinols.
Bradshaw TD; Matthews CS; Cookson J; Chew EH; Shah M; Bailey K; Monks A; Harris E; Westwell AD; Wells G; Laughton CA; Stevens MF
Cancer Res; 2005 May; 65(9):3911-9. PubMed ID: 15867391
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
9. A novel, broad-spectrum antitumor compound containing the 1-hydroxycyclohexa-2,5-dien-4-one group: the disclosure of a new antitumor pharmacophore in protoapigenone 1.
Yuan Q; Liu Z; Xiong C; Wu L; Wang J; Ruan J
Bioorg Med Chem Lett; 2011 Jun; 21(11):3427-30. PubMed ID: 21515048
[TBL] [Abstract][Full Text] [Related]
10. A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065.
Sato A; McNulty L; Cox K; Kim S; Scott A; Daniell K; Summerville K; Price C; Hudson S; Kiakos K; Hartley JA; Asao T; Lee M
J Med Chem; 2005 Jun; 48(11):3903-18. PubMed ID: 15916443
[TBL] [Abstract][Full Text] [Related]
11. Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines.
Mortimer CG; Wells G; Crochard JP; Stone EL; Bradshaw TD; Stevens MF; Westwell AD
J Med Chem; 2006 Jan; 49(1):179-85. PubMed ID: 16392802
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.
Marchand P; Antoine M; Le Baut G; Czech M; Baasner S; Günther E
Bioorg Med Chem; 2009 Sep; 17(18):6715-27. PubMed ID: 19682911
[TBL] [Abstract][Full Text] [Related]
13. Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity.
Schultz C; Link A; Leost M; Zaharevitz DW; Gussio R; Sausville EA; Meijer L; Kunick C
J Med Chem; 1999 Jul; 42(15):2909-19. PubMed ID: 10425100
[TBL] [Abstract][Full Text] [Related]
14. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, anti-inflammatory activity, and in vitro antitumor effect of a novel class of cyclooxygenase inhibitors: 4-(aryloyl)phenyl methyl sulfones.
Harrak Y; Casula G; Basset J; Rosell G; Plescia S; Raffa D; Cusimano MG; Pouplana R; Pujol MD
J Med Chem; 2010 Sep; 53(18):6560-71. PubMed ID: 20804197
[TBL] [Abstract][Full Text] [Related]
16. Substituted E-3-(2-Chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity.
Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Garaliene V; Farruggia G; Masotti L
Bioorg Med Chem; 2004 Mar; 12(5):1121-8. PubMed ID: 14980624
[TBL] [Abstract][Full Text] [Related]
17. N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: design, synthesis, SAR studies, and in vivo antitumor activity.
Wang H; Yu N; Song H; Chen D; Zou Y; Deng W; Lye PL; Chang J; Ng M; Sun ET; Sangthongpitag K; Wang X; Wu X; Khng HH; Fang L; Goh SK; Ong WC; Bonday Z; Stünkel W; Poulsen A; Entzeroth M
Bioorg Med Chem Lett; 2009 Mar; 19(5):1403-8. PubMed ID: 19181524
[TBL] [Abstract][Full Text] [Related]
18. Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.
Liou JP; Chang YL; Kuo FM; Chang CW; Tseng HY; Wang CC; Yang YN; Chang JY; Lee SJ; Hsieh HP
J Med Chem; 2004 Aug; 47(17):4247-57. PubMed ID: 15293996
[TBL] [Abstract][Full Text] [Related]
19. Antitumor quinols: role of glutathione in modulating quinol-induced apoptosis and identification of putative cellular protein targets.
Chew EH; Matthews CS; Zhang J; McCarroll AJ; Hagen T; Stevens MF; Westwell AD; Bradshaw TD
Biochem Biophys Res Commun; 2006 Jul; 346(1):242-51. PubMed ID: 16756956
[TBL] [Abstract][Full Text] [Related]
20. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
